Kyowa Kirin Co., Ltd. (TYO: 4151)
Japan
· Delayed Price · Currency is JPY
2,648.00
-18.00 (-0.68%)
Oct 11, 2024, 3:15 PM JST
Kyowa Kirin Revenue
Kyowa Kirin had revenue of 127.40B JPY in the quarter ending June 30, 2024, with 20.56% growth. This brings the company's revenue in the last twelve months to 476.00B, up 15.45% year-over-year. In the year 2023, Kyowa Kirin had annual revenue of 442.23B with 11.01% growth.
Revenue (ttm)
476.00B
Revenue Growth
+15.45%
P/S Ratio
2.98
Revenue / Employee
79.68M
Employees
5,974
Market Cap
1,392.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 442.23B | 43.86B | 11.01% |
Dec 31, 2022 | 398.37B | 46.13B | 13.09% |
Dec 31, 2021 | 352.25B | 33.89B | 10.65% |
Dec 31, 2020 | 318.35B | 12.53B | 4.10% |
Dec 31, 2019 | 305.82B | -40.71B | -11.75% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionKyowa Kirin News
- 16 days ago - Kyowa Kirin Announces Top-line Data from Rocatinlimab Phase 3 ROCKET HORIZON Trial for Adults with Moderate to Severe Atopic Dermatitis - PRNewsWire
- 22 days ago - Kyowa Kirin to Present New Research Spotlighting Global Efforts to Advance Science and Patient Care in X-linked Hypophosphatemia at ASBMR Annual Meeting - PRNewsWire
- 4 weeks ago - New Analysis Demonstrates Impaired Work Productivity and Increased Unemployment Rates in Adults with X-linked Hypophosphataemia (XLH) - Financial Post
- 7 weeks ago - Kyowa Kirin to end distribution of Fareston (toremefine) in the United States - PRNewsWire
- 2 months ago - Kyowa Kirin International and NewBridge Pharmaceuticals Enter Into Agreement to Improve Access to Medicines for Rare Disease Patients Across Middle East and North Africa - Business Wire
- 4 months ago - Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC - PRNewsWire
- 5 months ago - Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and Ophthalmology Annual Meeting 2024 - PRNewsWire
- 6 months ago - Kyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ® (istradefylline) and Other Parkinson's Disease Add-On Therapies - PRNewsWire